Skip to content

Clinical trials

Celiac Disease trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Celiac Disease Phase: Not applicable Clear all

124 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20031
20041
20061
20072
20084
20094
20102
20112
20125
20133
20143
201511
20167
20178
201812
20194
20205
20216
202210
20236
20245
20259
202610

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed64
Unknown status22
Recruiting18
Not yet recruiting7
Terminated6
Enrolling by invitation4
Suspended2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico7
University of Palermo7
McMaster University5
Boston Children's Hospital4
Oslo University Hospital4
Università Politecnica delle Marche4
Beth Israel Deaconess Medical Center3
Columbia University3
Massachusetts General Hospital3
Sheffield Teaching Hospitals NHS Foundation Trust3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Celiac Disease124
Irritable Bowel Syndrome10
Crohn Disease7
Inflammatory Bowel Diseases5
Disease4
Gastrointestinal Diseases4
Intestinal Diseases4
Autoimmune Diseases3
Colitis, Ulcerative3
Diabetes Mellitus, Type 13

Trials

Showing 76 to 100 of 124. Each trial links to its page on Pharma Observatory.

24 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.